Blood Journal
Leading the way in experimental and clinical research in hematology

The aryl hydrocarbon receptor directs hematopoietic progenitor cell expansion and differentiation

  1. Brenden W. Smith1,
  2. Sarah S. Rozelle1,
  3. Amy Leung1,
  4. Jessalyn Ubellacker2,
  5. Ashley Parks2,
  6. Shirley K. Nah3,
  7. Deborah French4,
  8. Paul Gadue4,
  9. Stefano Monti5,
  10. David H.K. Chui1,
  11. Martin H. Steinberg1,
  12. Andrew L. Frelinger6,
  13. Alan D. Michelson6,
  14. Roger Theberge7,
  15. Mark E. McComb7,
  16. Catherine E. Costello7,
  17. Darrell N. Kotton3,
  18. Gustavo Mostoslavsky3,
  19. David H. Sherr2, and
  20. George J. Murphy1,*
  1. 1 Section of Hematology and Oncology, Department of Medicine, Boston University School of Medicine, Boston, MA, United States;
  2. 2 Department of Environmental Health, Boston University School of Public Health, Boston, MA, United States;
  3. 3 Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, United States;
  4. 4 Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, United States;
  5. 5 Section of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, MA, United States;
  6. 6 Center for Platelet Research Studies, Division of Hematology/Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States;
  7. 7 Center for Biomedical Mass Spectrometry, Boston University School of Medicine, Boston, MA, United States
  1. * Corresponding author; email: gjmurphy{at}bu.edu
PDF Container